Yasmin Hurd, PhD
@neurovoice
Director of Addiction Institute & Chair of Translational Neuro @IcahnMountSinai. PI @HurdLab. Research on genes x environment x addiction. Working to #EndStigma
Is stronger cannabis leading to a rise in dependence? What is the relationship between cannabis potency & adolescent #cannabis use disorder (CUD)... Our new commentary in @APAPubJournals explores this & proposes improvements to research & treatment 🧵 ajp.psychiatryonline.org/doi/10.1176/ap…
Our research shows the impact of #cannabis on the developing brain. I spoke to Dr. Delaney Ruston about how #THC exposure in adolescent rats alters cell communication vital for cognitive function. Watch more: youtube.com/watch?v=f2Eb2L…
I recently had the pleasure of meeting tennis player @AnisimovaAmanda! 🤩 🎾 I'm so inspired by her persistence & resilience. As scientists, we can learn a lot from her on how to handle victory & defeat. Win or lose in the research game, let’s grow with grace & keep showing up.
The #cannabis landscape has changed. High THC concentrations in today's products have profound effects on the brain 🧠 I spoke with @dougbopst on The Adversity Advantage about the risks of cannabis consumption. 🎧 Listen here: podcasts.apple.com/bb/podcast/can…
🧠 We know that #cannabis use can disrupt adolescent brain development and behavior, but individual differences and THC potency can impact that trajectory 🤔 For a deeper dive into current cannabis findings and future directions for research, click here: psychiatryonline.org/doi/10.1176/ap…
We recently celebrated the graduating cohort from our CARES youth program. The commitment and strength this group has shown demonstrates how life trajectories can change with the proper support and the impact our program has on those seeking help. Congratulations graduates 🎉
We are long overdue for more research on the benefits and risks of #cannabis use. While this research is in progress, we certainly need better policy for product standards and public education. Read more in the @APA's June Report: apa.org/monitor/2025/2…
I'm looking forward to speaking at @CAN_ACN's annual meeting tomorrow! I’ll be talking about all things #Cannabis, including our current preclinical and human research that is relevant to policy and expanding consumer knowledge. Come say hello!
To all those descending onto Toronto in the next day or two for the @CAN_ACN annual meeting, as program chair I hope you have a on invigorating and exciting meeting and enjoy our featured speakers @Franklandlab @yulonglilab @neurovoice Kerry Ressler and Gina Turrigiano #CAN2025
🤔 Today’s #cannabis products are shaped largely by commercial interests, which means consumer health & wellbeing isn’t always the top priority. I encourage consumers to evaluate these products & know the potential risks. Read more here: washingtoncitypaper.com/article/762463…
Thanks for chatting with me @i_am_julie_rose! Today’s #cannabis has much more potent THC than in the past. How we think about & approach cannabis needs to change with this in mind - from policy & consumer perspectives. 🎧 Listen to our discussion here: open.spotify.com/show/5P43AGNPW…
Is it time to rethink how we talk about cannabis? According to @neurovoice, cannabis is a far more complex drug than we previously thought. The marijuana on today’s market is nothing like the Woodstock era, and it's causing real public health issues. Learn more with Top of Mind.
Our AIMS event last week was a hit 🎉 So warmed by the incredible feedback! Attendees shared how much they appreciated learning about #cannabis across clinical care, translational research & preclinical work. Special thanks to the expert speakers who made this event possible!
📣 Next week, @AIMSNYC is hosting the Annual Dr. Robert Newman Lecture, featuring the topic "Cannabis Across the Lifespan." Join us for a Keynote by Dr. Hugh Garavan and panel discussions with leading #cannabis researchers. RSVP today: docs.google.com/forms/d/e/1FAI…
In a recent episode of @ISSUESinST, I talked about the complexity of #cannabis regulations and the need for better policies and education for the public. 🎧 Listen here: issues.org/minimizing-can…
✒️ I wrote a Behind the Paper post for @SpringerNature about my lab's latest paper. Learn all about our exciting new work on how #CBD can mitigate #anxiety. Read the post here: communities.springernature.com/posts/unraveli…
New Hurd Lab translational study used machine learning to identify the Shisa7 gene’s role in opioid addiction. This exciting work contributes to our understanding of the neurobiological basis of addiction. 📚 Read about our finding in @BiologicalPsyc1: biologicalpsychiatryjournal.com/article/S0006-…
Despite cannabis policy directly affecting how the public interacts with #cannabis products, we have very little data on the public health implications of policies that have been instated over the past few decades. 🎧 Listen to the discussion here: podcast.publichealth.jhu.edu/853-the-hazy-w…
As the public's relationship with cannabis changes, so should national policy. Again, we call on public health officials to do more to educate the public on the potential harms of cannabis use, especially on the brain 🧠 Read about my work and the @theNASEM's report 👇🏾
Dr. Yasmin Hurd's research focuses on the impact of cannabis on neurodevelopment, especially among those at risk of substance use disorder. Now, w/ increasing potency & little regulatory oversight, her work plays a key role in a call for better education. reports.mountsinai.org/article/psych2…
ACAAM Members: Don't miss tomorrow's session on "Cannabidiol and Addiction: Separating Science from Fiction," presented by Yasmin Hurd, PhD, from @IcahnMountSinai. Check your Weekly Didactic Series Reminder for the Zoom link! @neurovoice #AddictionMedicine